CS
IMUX icon

Credit Suisse’s Immunic IMUX Stock Holding History

Credit Suisse’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed – – 4147
2022
Q2 		$0 Buy
+1
New +$64 ﹤0.01% 4108
2018
Q1 		– Sell
-34
Closed -$80K – 4044
2017
Q4 		$80K Buy
+34
New +$75.2K ﹤0.01% 3866
2017
Q3 		– Sell
-153
Closed -$177K – 4215
2017
Q2 		$177K Buy
+153
New +$204K ﹤0.01% 3643
2016
Q4 		– Sell
-33
Closed -$81K – 4153
2016
Q3 		$81K Sell
33
-37
-53% -$91.3K ﹤0.01% 3957
2016
Q2 		$172K Buy
+70
New +$230K ﹤0.01% 3921
2016
Q1 		– Sell
-27
Closed -$124K – 4135
2015
Q4 		$124K Sell
27
-6
-18% -$19.6K ﹤0.01% 4042
2015
Q3 		$54K Buy
+33
New +$165K ﹤0.01% 4167

Other funds holding IMUX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Credit Suisse's IMUX Position: Q3 2022 in Review

Credit Suisse sold out of Immunic (IMUX) in Q3 2022, closing a stake of 1 share.

Credit Suisse first reported a position in IMUX in Q3 2015 and held it in 7 quarters. The position peaked at $177K in Q2 2017. 65 funds tracked by Wall St. Rank hold IMUX as of Q3 2022.

  • Credit Suisse reported no remaining Immunic position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 1 Immunic share in Q3 2022.
  • Credit Suisse first reported a position in Immunic in Q3 2015 and held it in 7 quarters.
  • Credit Suisse's Immunic position peaked at $177K in Q2 2017.
  • 65 funds tracked by Wall St. Rank held Immunic as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.